Organisation paid for research Program year 2024 Source: CMS Open Payments

Pharmaceutical Research Org

Neither a doctor nor a teaching hospital

Research payments

$830,237

152 payments

Through program year 2024, Pharmaceutical Research Org is reported as receiving $830,237 in research payments, across 152 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$10,710	19
2023	Research	$378,326	74
2022	Research	$207,089	30
2021	Research	$55,492	11
2020	Research	$117,855	6
2019	Research	$60,764	12

Breakdown

Who paid Research payments · program years 2019–2024

GlaxoSmithKline, LLC. $603,239 120 payments
AstraZeneca Pharmaceuticals LP $190,333 24 payments
AstraZeneca UK Limited $36,665 8 payments

Studies the money was for Research payments · program years 2019–2024

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY) $219,628 26 payments
A Phase III, Randomized, Controlled, Observer-Blind Study to Demonstra $192,141 27 payments
A Phase II, Observer-Blind, Randomized, Controlled Study to Evaluate T $173,336 35 payments
Phase Iiib, Observer-Blind, Randomized, Placebo-Controlled, Multi-Cent $147,854 36 payments
A Phase III, Randomized, Controlled, Observer-Blind Study to Evaluate $42,955 7 payments
A Phase 2B, Randomized, Observer-Blinded Trial to Describe the Safety, $18,824 3 payments
A Phase 3, Open-Label, Randomized, Controlled, Multi Country Study to $17,644 4 payments
A Phase 3, Randomized, Placebo-Controlled, Observer-Blind, Multi-Count $8,476 6 payments
MEDI8897 RSV mAb-D5290C00003 Phase 2 / 2b Clinical Trial $7,370 6 payments
Phase 3B, Randomized, Observer-Blind. Multicenter Study to Assess the $2,010 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.